748 related articles for article (PubMed ID: 24506593)
1. A modern Monte Carlo investigation of the TG-43 dosimetry parameters for an 125I seed already having AAPM consensus data.
Aryal P; Molloy JA; Rivard MJ
Med Phys; 2014 Feb; 41(2):021702. PubMed ID: 24506593
[TBL] [Abstract][Full Text] [Related]
2. Monte Carlo-aided dosimetry of the theragenics TheraSeed model 200 103Pd interstitial brachytherapy seed.
Monroe JI; Williamson JF
Med Phys; 2002 Apr; 29(4):609-21. PubMed ID: 11991133
[TBL] [Abstract][Full Text] [Related]
3. Update of AAPM Task Group No. 43 Report: A revised AAPM protocol for brachytherapy dose calculations.
Rivard MJ; Coursey BM; DeWerd LA; Hanson WF; Huq MS; Ibbott GS; Mitch MG; Nath R; Williamson JF
Med Phys; 2004 Mar; 31(3):633-74. PubMed ID: 15070264
[TBL] [Abstract][Full Text] [Related]
4. Monte Carlo calculations and experimental measurements of the TG-43U1-recommended dosimetric parameters of 125I (Model IR-Seed2) brachytherapy source.
Sheikholeslami S; Nedaie HA; Sadeghi M; Pourbeigy H; Shahzadi S; Zehtabian M; Hasani M; Meigooni AS
J Appl Clin Med Phys; 2016 Jul; 17(4):430-441. PubMed ID: 27455485
[TBL] [Abstract][Full Text] [Related]
5. Study of the IsoAid ADVANTAGE (125)I brachytherapy source dosimetric parameters using Monte Carlo simulation.
Sadeghi M; Hamed Hosseini S
Appl Radiat Isot; 2010 Jan; 68(1):211-3. PubMed ID: 19762248
[TBL] [Abstract][Full Text] [Related]
6. Monte Carlo and thermoluminescence dosimetry of the new IsoSeed model I25.S17 125I interstitial brachytherapy seed.
Lymperopoulou G; Papagiannis P; Sakelliou L; Karaiskos P; Sandilos P; Przykutta A; Baltas D
Med Phys; 2005 Nov; 32(11):3313-7. PubMed ID: 16370418
[TBL] [Abstract][Full Text] [Related]
7. Monte Carlo dosimetry of the selectSeed 125I interstitial brachytherapy seed.
Karaiskos P; Papagiannis P; Sakelliou L; Anagnostopoulos G; Baltas D
Med Phys; 2001 Aug; 28(8):1753-60. PubMed ID: 11548946
[TBL] [Abstract][Full Text] [Related]
8. Dosimetric characterization of the M-15 high-dose-rate Iridium-192 brachytherapy source using the AAPM and ESTRO formalism.
Ho Than MT; Munro Iii JJ; Medich DC
J Appl Clin Med Phys; 2015 May; 16(3):5270. PubMed ID: 26103489
[TBL] [Abstract][Full Text] [Related]
9. An experimental palladium-103 seed (OptiSeedexp) in a biocompatible polymer without a gold marker: characterization of dosimetric parameters including the interseed effect.
Abboud F; Scalliet P; Vynckier S
Med Phys; 2008 Dec; 35(12):5841-50. PubMed ID: 19175140
[TBL] [Abstract][Full Text] [Related]
10. An evaluation of the AAPM-TG43 dosimetry protocol for I-125 brachytherapy seed.
Mobit P; Badragan I
Phys Med Biol; 2004 Jul; 49(14):3161-70. PubMed ID: 15357189
[TBL] [Abstract][Full Text] [Related]
11. Dosimetric characteristics of the Pharma Seed model BT-125-I source.
Popescu CC; Wise J; Sowards K; Meigooni AS; Ibbott GS
Med Phys; 2000 Sep; 27(9):2174-81. PubMed ID: 11011748
[TBL] [Abstract][Full Text] [Related]
12. EchoSeed Model 6733 Iodine-125 brachytherapy source: improved dosimetric characterization using the MCNP5 Monte Carlo code.
Mosleh-Shirazi MA; Hadad K; Faghihi R; Baradaran-Ghahfarokhi M; Naghshnezhad Z; Meigooni AS
Med Phys; 2012 Aug; 39(8):4653-9. PubMed ID: 22894389
[TBL] [Abstract][Full Text] [Related]
13. Monte Carlo calculations of AAPM Task Group Report No. 43 dosimetry parameters for the (125)I I-Seed AgX100 source model.
Mourtada F; Mikell J; Ibbott G
Brachytherapy; 2012; 11(3):237-44. PubMed ID: 21816684
[TBL] [Abstract][Full Text] [Related]
14. Monte Carlo calculations of AAPM Task Group Report No. 43 dosimetry parameters for the MED3631-A/M125I source.
Rivard MJ
Med Phys; 2001 Apr; 28(4):629-37. PubMed ID: 11339761
[TBL] [Abstract][Full Text] [Related]
15. Polymer gel dosimetry for the TG-43 dosimetric characterization of a new 125I interstitial brachytherapy seed.
Papagiannis P; Pantelis E; Georgiou E; Karaiskos P; Angelopoulos A; Sakelliou L; Stiliaris S; Baltas D; Seimenis I
Phys Med Biol; 2006 Apr; 51(8):2101-11. PubMed ID: 16585848
[TBL] [Abstract][Full Text] [Related]
16. Brachytherapy dosimetry parameters calculated for a 131Cs source.
Rivard MJ
Med Phys; 2007 Feb; 34(2):754-62. PubMed ID: 17388193
[TBL] [Abstract][Full Text] [Related]
17. A Monte Carlo evaluation of the dosimetric characteristics of the EchoSeed Model 6733 (125)I brachytherapy source.
Sowards KT; Meigooni AS
Brachytherapy; 2002; 1(4):227-32. PubMed ID: 15062171
[TBL] [Abstract][Full Text] [Related]
18. Experimental and theoretical dosimetry of a new polymer encapsulated iodine-125 source--SmartSeed: dosimetric impact of fluorescence x rays.
Abboud F; Hollows M; Scalliet P; Vynckier S
Med Phys; 2010 May; 37(5):2054-62. PubMed ID: 20527538
[TBL] [Abstract][Full Text] [Related]
19. Monte Carlo calculated TG-43 dosimetry parameters for the SeedLink 125Iodine brachytherapy system.
Medich DC; Munro JJ
Med Phys; 2003 Sep; 30(9):2503-8. PubMed ID: 14528972
[TBL] [Abstract][Full Text] [Related]
20. The use of new GAFCHROMIC EBT film for 125I seed dosimetry in Solid Water phantom.
Chiu-Tsao ST; Medich D; Munro J
Med Phys; 2008 Aug; 35(8):3787-99. PubMed ID: 18777938
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
